Aridis Pharmaceuticals (OTC:ARDS) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Aridis Pharmaceuticals (ARDS) operate in?

Aridis Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.

Aridis Pharmaceuticals Stock (OTC: ARDS) stock price, news, charts, stock research, profile.

Open	$0.00
Close	-
Volume / Avg.	250.00 / 104.20K
Day Range	$0.00 - $0.00
52 Wk Range	0.00 - 0.12
Market Cap	$44.00
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1.04

Recent News

Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring.

Lisa Levin

Why Are Aridis Pharmaceuticals Shares Moving Higher Today?

Aridis Pharmaceuticals Inc (NASDAQ: ARDS) shares are gaining after announcing positive European Medicines Agency feedback on its proposed single confirmatory Phase 3 study of investigational monoclonal

Vandana Singh

Why Biophytis Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket

Gainers Biophytis S.A. (NASDAQ: BPTS) shares surged 53.9% to $3.31 in pre-market trading after the company signed a partnership with SEQENS to produce Sarconeos (BIO101) active compound, the company's main product.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Aridis Pharmaceuticals Inc

Sector

Health Care

Industry

Biotechnology

Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Aridis Pharmaceuticals (ARDS) stock?

You can purchase shares of Aridis Pharmaceuticals (OTCEM:ARDS) through any online brokerage.

View our list of the best stock brokerages

Who are Aridis Pharmaceuticals (ARDS) competitors?

There are no as such competitors for Aridis Pharmaceuticals.

What is the forecast, or price target, for Aridis Pharmaceuticals (ARDS) stock?

Aridis Pharmaceuticals has a consensus price target of $2.00.

What is the current price for Aridis Pharmaceuticals (ARDS)?

The stock price for Aridis Pharmaceuticals (OTCEM: ARDS) is $0.064 last updated July 16, 2024 at 8:13 AM EDT.

Does Aridis Pharmaceuticals (ARDS) pay a dividend?

There are no upcoming dividends for Aridis Pharmaceuticals.

When is Aridis Pharmaceuticals (OTCEM:ARDS) reporting earnings?

Aridis Pharmaceuticals’s Q3 earnings are confirmed for Friday, November 1, 2024.

Is Aridis Pharmaceuticals (ARDS) going to split?

There is no upcoming split for Aridis Pharmaceuticals.

What sector and industry does Aridis Pharmaceuticals (ARDS) operate in?

Aridis Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now